From January 1, 2024 to March 31, 2024, the company has repurchased 7,553,900 shares, representing 0.64% for CNY 67.18 million. With this, the company has completed the repurchase of 7,829,900 shares, representing 0.66% for CNY 69.72 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 CNY | -1.87% | -1.76% | -10.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.36% | 136.82Cr | |
+35.01% | 71TCr | |
+30.71% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.40% | 24TCr | |
+9.30% | 21TCr | |
-3.44% | 20TCr | |
+10.77% | 17TCr |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.